BENGALURU: Goldman Sachs Group Inc chief executive officer (CEO) David Solomon on Wednesday apologised to Malaysians for former banker Tim Leissner’s role in the sovereign wealth fund 1Malaysia Development Bhd (1MDB) scandal, but said the bank had conducted due diligence before every transaction.
Goldman is being investigated by Malaysian authorities and the US Department of Justice (DoJ) for its role as underwriter and arranger of three bond sales that raised US$6.5 billion for 1MDB.
SAP has launched a blockchain-based supply chain tracking system to allow drug wholesalers to authenticate pharmaceutical packaging returned by pharmacies and hospitals. That should help them weed out counterfeit drugs from their supply chain. SAP says it hopes to eventually expand the use of distributed ledger technology to cover a broader range of pharmaceutical supply chain processes. According to the company, its blockchain-based solution helps customers comply with the US Drug Supply Chain Security Act (DSCSA), which establishes that as of November 2019, wholesalers must verify prescription drugs that are returned and intended for resale. This piece of legislation is… This story continues at The Next Web